Measuring Quoted Investments in Subsidiaries, Joint ... ?· The IASB proposes to amend IFRS 10, IFRS…

Download Measuring Quoted Investments in Subsidiaries, Joint ... ?· The IASB proposes to amend IFRS 10, IFRS…

Post on 09-Sep-2018

212 views

Category:

Documents

0 download

Embed Size (px)

TRANSCRIPT

<ul><li><p>Exposure Draft ED/2014/4</p><p>September 2014</p><p>Comments to be received by 16 January 2015</p><p>Measuring Quoted Investments in Subsidiaries, Joint Ventures and Associates at Fair ValueProposed amendments to IFRS 10, IFRS 12, IAS 27, IAS 28 and IAS 36 and Illustrative Examples for IFRS 13</p><p>bahrmannTextfeld32. Sitzung IFRS-FA am 03.11.201432_06b_IFRS-FA_MQI_ED</p></li><li><p>Measuring Quoted Investments inSubsidiaries, Joint Ventures and</p><p>Associates at Fair Value</p><p>(Proposed amendments to IFRS 10,IFRS 12, IAS 27, IAS 28 and IAS 36 and</p><p>Illustrative Examples for IFRS 13)</p><p>Comments to be received by 16 January 2015</p></li><li><p>Exposure Draft ED/2014/4 Measuring Quoted Investments in Subsidiaries, Joint Ventures and Associates atFair Value (Proposed amendments to IFRS 10, IFRS 12, IAS 27, IAS 28 and IAS 36 and IllustrativeExamples for IFRS 13) is published by the International Accounting Standards Board (IASB) for</p><p>comment only. The proposals may be modified before being issued in final form. Comments</p><p>need to be received by 16 January 2015 and should be submitted in writing to the address below</p><p>or electronically using our Comment on a proposal page.</p><p>All comments will be on the public record and posted on our website unless the respondent</p><p>requests confidentiality. Such requests will not normally be granted unless supported by good</p><p>reason, for example, commercial confidence. Please see our website for details on this and how</p><p>we use your personal data.</p><p>Disclaimer: the IASB, the IFRS Foundation, the authors and the publishers do not accept</p><p>responsibility for any loss caused by acting or refraining from acting in reliance on the material</p><p>in this publication, whether such loss is caused by negligence or otherwise.</p><p>International Financial Reporting Standards (including International Accounting Standards and</p><p>SIC and IFRIC Interpretations), Exposure Drafts and other IASB and/or IFRS Foundation</p><p>publications are copyright of the IFRS Foundation.</p><p>Copyright 2014 IFRS Foundation</p><p>ISBN: 978-1-909704-51-0</p><p>All rights reserved. Copies of the Exposure Draft may only be made for the purpose of preparing</p><p>comments to the IASB provided that such copies are for personal or internal use, are not sold or</p><p>otherwise disseminated, acknowledge the IFRS Foundations copyright and set out the IASBs</p><p>address in full.</p><p>Except as permitted above no part of this publication may be translated, reprinted, reproduced or</p><p>used in any form either in whole or in part or by any electronic, mechanical or other means, now</p><p>known or hereafter invented, including photocopying and recording, or in any information</p><p>storage and retrieval system, without prior permission in writing from the IFRS Foundation.</p><p>The approved text of International Financial Reporting Standards and other IASB publications is</p><p>that published by the IASB in the English language. Copies may be obtained from the IFRS</p><p>Foundation. Please address publications and copyright matters to:</p><p>IFRS Foundation Publications Department</p><p>30 Cannon Street, London EC4M 6XH, United Kingdom</p><p>Tel: +44 (0)20 7332 2730 Fax: +44 (0)20 7332 2749</p><p>Email: publications@ifrs.org Web: www.ifrs.org</p><p>The IFRS Foundation logo/the IASB logo/the IFRS for SMEs logo/Hexagon Device, IFRS</p><p>Foundation, IFRS Taxonomy, eIFRS, IASB, IFRS for SMEs, IAS, IASs, IFRIC, IFRS, IFRSs,</p><p>SIC, International Accounting Standards and International Financial Reporting Standards are</p><p>Trade Marks of the IFRS Foundation.</p><p>The IFRS Foundation is a not-for-profit corporation under the General Corporation Law of the</p><p>State of Delaware, USA and operates in England and Wales as an overseas company (Company</p><p>number: FC023235) with its principal office as above.</p></li><li><p>CONTENTS</p><p>from page</p><p>INTRODUCTION 4</p><p>INVITATION TO COMMENT 4</p><p>[DRAFT] AMENDMENTS TO IFRS 10 CONSOLIDATED FINANCIALSTATEMENTS 7</p><p>[DRAFT] AMENDMENTS TO IFRS 12 DISCLOSURE OF INTERESTS IN OTHERENTITIES 10</p><p>[DRAFT] AMENDMENTS TO IAS 27 SEPARATE FINANCIAL STATEMENTS 11</p><p>[DRAFT] AMENDMENTS TO IAS 28 INVESTMENTS IN ASSOCIATES ANDJOINT VENTURES 14</p><p>[DRAFT] AMENDMENTS TO IAS 36 IMPAIRMENT OF ASSETS 16</p><p>[DRAFT] AMENDMENTS TO THE ILLUSTRATIVE EXAMPLES FOR IFRS 13FAIR VALUE MEASUREMENT 18</p><p>APPROVAL OF THE EXPOSURE DRAFT BY THE BOARD 20</p><p>BASIS FOR CONCLUSIONS ON THE EXPOSURE DRAFT 21</p><p>DISSENTING OPINION 30</p><p>MEASURING QUOTED INVESTMENTS IN SUBSIDIARIES, JOINT VENTURES AND ASSOCIATES AT FAIR VALUE</p><p> IFRS Foundation3</p></li><li><p>Introduction</p><p>The International Accounting Standards Board (IASB) has published this Exposure Draft to</p><p>propose amendments to IFRS 10 Consolidated Financial Statements, IFRS 12 Disclosure of Interestsin Other Entities, IAS 27 Separate Financial Statements, IAS 28 Investments in Associates and JointVentures and IAS 36 Impairment of Assets.</p><p>This Exposure Draft addresses questions received on the unit of account for investments in</p><p>subsidiaries, joint ventures and associates and on their fair value measurement when those</p><p>investments are quoted in an active market (quoted investments). Similarly, the IASB also</p><p>received questions on the measurement of the recoverable amount of cash-generating units</p><p>(CGUs) on the basis of fair value less costs of disposal when they correspond to entities that</p><p>are quoted in an active market (quoted CGUs).</p><p>The proposed amendments clarify that an entity should measure the fair value of quoted</p><p>investments and quoted CGUs as the product of the quoted price for the individual financial</p><p>instruments that make up the investments held by the entity and the quantity of financial</p><p>instruments.</p><p>This Exposure Draft also sets out proposed amendments to the Illustrative Examples for</p><p>IFRS 13 Fair Value Measurement to illustrate the application of paragraph 48 of that Standardfor a specific case. The example illustrates the fair value measurement of an entitys net</p><p>exposure to market risks arising from a group of financial assets and financial liabilities</p><p>whose market risks are substantially the same and whose fair value measurement is</p><p>categorised within Level 1 of the fair value hierarchy.</p><p>Invitation to comment</p><p>The IASB invites comments on the proposals in this Exposure Draft, particularly on the</p><p>questions set out below. Comments are most helpful if they:</p><p>(a) comment on the questions as stated;</p><p>(b) indicate the specific paragraph(s) to which they relate;</p><p>(c) contain a clear rationale; and</p><p>(d) describe any alternative that the IASB should consider, if applicable.</p><p>The IASB is not requesting comments on matters in IFRS 10, IFRS 12, IAS 27, IAS 28, IAS 36</p><p>and Illustrative Examples for IFRS 13 that are not addressed in this Exposure Draft. The</p><p>IASB will consider all comments received in writing by 16 January 2015. In considering thecomments, the IASB will base its conclusions on the merits of the arguments for and against</p><p>each alternative, not on the number of responses supporting each one.</p><p>EXPOSURE DRAFTSEPTEMBER 2014</p><p> IFRS Foundation 4</p></li><li><p>Questions for respondents</p><p>Question 1The unit of account for investments in subsidiaries, joint venturesand associates</p><p>The IASB concluded that the unit of account for investments within the scope of</p><p>IFRS 10, IAS 27 and IAS 28 is the investment as a whole rather than the individual</p><p>financial instruments included within that investment (see paragraphs BC3BC7).</p><p>Do you agree with this conclusion? If not, why and what alternative do you propose?</p><p>Question 2Interaction between Level 1 inputs and the unit of account forinvestments in subsidiaries, joint ventures and associates</p><p>The IASB proposes to amend IFRS 10, IFRS 12, IAS 27 and IAS 28 to clarify that the fair</p><p>value measurement of quoted investments in subsidiaries, joint ventures and associates</p><p>should be the product of the quoted price (P) multiplied by the quantity of financial</p><p>instruments held (Q), or P Q, without adjustments (see paragraphs BC8BC14).</p><p>Do you agree with the proposed amendments? If not, why and what alternative do you</p><p>propose? Please explain your reasons, including commenting on the usefulness of the</p><p>information provided to users of financial statements.</p><p>Question 3Measuring the fair value of a CGU that corresponds to a quoted entity</p><p>The IASB proposes to align the fair value measurement of a quoted CGU to the fair value</p><p>measurement of a quoted investment. It proposes to amend IAS 36 to clarify that the</p><p>recoverable amount of a CGU that corresponds to a quoted entity measured on the basis</p><p>of fair value less costs of disposal should be the product of the quoted price (P)</p><p>multiplied by the quantity of financial instruments held (Q), or P Q, without</p><p>adjustments (see paragraphs BC15BC19). To determine fair value less costs of disposal,</p><p>disposal costs are deducted from the fair value amount measured on this basis.</p><p>Do you agree with the proposed amendments? If not, why and what alternative do you</p><p>propose?</p><p>Question 4Portfolios</p><p>The IASB proposes to include an illustrative example to IFRS 13 to illustrate the</p><p>application of paragraph 48 of that Standard to a group of financial assets and financial</p><p>liabilities whose market risks are substantially the same and whose fair value</p><p>measurement is categorised within Level 1 of the fair value hierarchy. The example</p><p>illustrates that the fair value of an entitys net exposure to market risks arising from</p><p>such a group of financial assets and financial liabilities is to be measured in accordance</p><p>with the corresponding Level 1 prices.</p><p>Do you think that the proposed additional illustrative example for IFRS 13 illustrates</p><p>the application of paragraph 48 of IFRS 13? If not, why and what alternative do you</p><p>propose?</p><p>MEASURING QUOTED INVESTMENTS IN SUBSIDIARIES, JOINT VENTURES AND ASSOCIATES AT FAIR VALUE</p><p> IFRS Foundation5</p></li><li><p>Question 5Transition provisions</p><p>The IASB proposes that for the amendments to IFRS 10, IAS 27 and IAS 28, an entity</p><p>should adjust its opening retained earnings, or other component of equity, as</p><p>appropriate, to account for any difference between the previous carrying amount of the</p><p>quoted investment(s) in subsidiaries, joint ventures or associates and the carrying</p><p>amount of those quoted investment(s) at the beginning of the reporting period in which</p><p>the amendments are applied. The IASB proposes that the amendments to IFRS 12 and</p><p>IAS 36 should be applied prospectively.</p><p>The IASB also proposes disclosure requirements on transition (see paragraphs</p><p>BC32BC33) and to permit early application (see paragraph BC35).</p><p>Do you agree with the transition methods proposed (see paragraphs BC30BC35)? If not,</p><p>why and what alternative do you propose?</p><p>How to commentComments should be submitted using one of the following methods.</p><p>Electronically</p><p>(our preferred method)</p><p>Visit the Comment on a proposal page, which can be found at:go.ifrs.org/comment</p><p>Email Email comments can be sent to: commentletters@ifrs.org</p><p>Postal IFRS Foundation30 Cannon StreetLondon EC4M 6XHUnited Kingdom</p><p>All comments will be on the public record and posted on our website unless confidentiality</p><p>is requested. Such requests will not normally be granted unless supported by good reason,</p><p>for example, commercial confidence. Please see our website for details on this and how we</p><p>use your personal data.</p><p>EXPOSURE DRAFTSEPTEMBER 2014</p><p> IFRS Foundation 6</p></li><li><p>[Draft] Amendments toIFRS 10 Consolidated Financial Statements</p><p>Paragraph 31 is amended. New text is underlined.</p><p>Investment entities: exception to consolidation</p><p>31 Except as described in paragraph 32, an investment entity shall notconsolidate its subsidiaries or apply IFRS 3 when it obtains control ofanother entity. Instead, an investment entity shall measure aninvestment in a subsidiary at fair value through profit or loss inaccordance with IFRS 9.2 When an investment entity has an investment ina subsidiary that is quoted in an active market, its fair value shall be theproduct of the quoted price multiplied by the quantity of the financialinstruments that make up the investment, without adjustment, inaccordance with IFRS 13 Fair Value Measurement.</p><p>In Appendix C, paragraph C1D and paragraphs C6CC6D and their related heading areadded. New text is underlined.</p><p>Effective date</p><p>...</p><p>C1D [Draft] Measuring Quoted Investments in Subsidiaries, Joint Ventures and Associates at FairValue (Amendments to IFRS 10, IFRS 12, IAS 27, IAS 28 and IAS 36 and IllustrativeExamples for IFRS 13), issued in [date], amended paragraph 31 and added</p><p>paragraphs C6CC6D and their related heading. An entity shall apply those</p><p>amendments for annual periods beginning on or after 1 January 201X. Earlier</p><p>application is permitted. If an entity applies those amendments earlier, it shall</p><p>disclose that fact and apply the amendments to IFRS 12, IAS 27, IAS 28 and</p><p>IAS 36 at the same time. The transition requirements of those amendments are</p><p>detailed in paragraphs C6CC6D.</p><p>...</p><p>Transition</p><p>...</p><p>Measuring quoted investments in subsidiaries at fairvalue</p><p>C6C At the date of initial application of the amendments referred to in paragraph</p><p>C1D, an entity shall adjust its opening retained earnings to account for any</p><p>difference between the previous carrying amount of the investment(s) in a</p><p>MEASURING QUOTED INVESTMENTS IN SUBSIDIARIES, JOINT VENTURES AND ASSOCIATES AT FAIR VALUE</p><p> IFRS Foundation7</p></li><li><p>subsidiary(ies) that is quoted in an active market and the carrying amount of</p><p>that quoted investment(s) at the beginning of the reporting period in which the</p><p>amendments are first applied.</p><p>C6D For investments in subsidiaries that are quoted in an active market at the date</p><p>that the amendments are initially applied, an entity shall disclose the effect of</p><p>the amendments recognised in its opening retained earnings for the reporting</p><p>period in which the amendments are first applied.</p><p>EXPOSURE DRAFTSEPTEMBER 2014</p><p> IFRS Foundation 8</p></li><li><p>[Draft] Amendments to the Basis for Conclusions onIFRS 10 Consolidated Financial Statements</p><p>The following footnote is added to paragraph BC283 and to the second sentence ofparagraph BC296. New text is underlined.</p><p>[Draft] Measuring Quoted Investments in Subsidiaries, Joint Ventures and Associates at Fair Value(Amendments to IFRS 10, IFRS 12, IAS 27, IAS 28 and IAS 36 and Illustrative Examples for</p><p>IFRS 13), issued in [date], requires that the measurement of investments in subsidiaries,</p><p>joint ventures and associates that are quoted in an active market at fair value, and the</p><p>measurement of the recoverable amount of cash-generating units that correspond to</p><p>entities that are quoted in an active market on the basis of fair value less costs of disposal,</p><p>shall be determined by multiplying the quoted prices by the quantity of the financial</p><p>instruments that make up those investments or cash-generating units, without adjustment,</p><p>in accordance with IFRS 13.</p><p>MEASURING QUOTED INVESTMENTS IN SUBSIDIARIES, JOINT VENTURES AND ASSOCIATES AT FAIR VALUE</p><p> IFRS Foundation9</p></li><li><p>[Draft] Amendments toIFRS 12 Disclosure of Interests in Other Entities</p><p>Paragraph 21 is amended. New text is underlined.</p><p>Nature, extent and financial effects of an entitysinterests in joint arrangements and associates</p><p>21 An entity shall disclose:</p><p>(a) ...</p><p>(b) for each joint venture and associate that is material to the reporting</p><p>entity:</p><p>(i) </p><p>(iii) if the joint venture o...</p></li></ul>

Recommended

View more >